Coherus Oncology, Inc.

Nasdaq:CHRS

Biological Products, (No Diagnostic Substances)·REDWOOD CITY, CA

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/9/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/17/25	→
10-Q	Q3 2024	9/30/24	11/6/24	→
↓

Earnings Releases (8-K)

21 shown

Filed	Period
3/9/26	Q1 FY2026	→
1/13/26	Q4 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
3/10/25	Q1 FY2025	→
↓

News (8-K)

59 shown

Filed	Type	Description
2/17/26	Other	Other Events	→
2/4/26	Other	Other Events	→
1/23/26	Other	Other Events	→
11/13/25	Other	Other Events	→
9/8/25	Other	Other Events	→
7/3/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/13/26	424B5	424B5	→
2/12/26	424B5	424B5	→
1/23/26	424B5	424B5	→
11/13/25	S-3	S-3	→
11/13/25	S-8	S-8	→
4/29/25	ARS	ARS	→
↓

Filing History(886 filings)

TypeDateAccessionPeriodSize

10-K

Mar 9, 2026

0001104659-26-02530810-K

Dec 31, 2025

14.7 MB

8-K

Mar 9, 2026

0001104659-26-0252938-K

Mar 9, 2026

522.3 KB

8-K

Feb 17, 2026

0001104659-26-0163788-K

Feb 12, 2026

550.6 KB

424B5

Feb 13, 2026

0001104659-26-015358424B5

—

706.1 KB

424B5

Feb 12, 2026

0001104659-26-014280424B5

—

707.1 KB

SCHEDULE 13G

Feb 5, 2026

0002109159-26-000001

—

8.4 KB

8-K

Feb 4, 2026

0001104659-26-0100658-K

Feb 4, 2026

152.9 KB

SCHEDULE 13G/A

Jan 30, 2026

0000102909-26-000318

—

7.3 KB

Jan 26, 2026

0001610717-26-000027

Jan 23, 2026

9.1 KB

Jan 26, 2026

0001610717-26-000026

Jan 22, 2026

7.3 KB

8-K

Jan 23, 2026

0001104659-26-006307FORM 8-K

Jan 23, 2026

225.9 KB

424B5

Jan 23, 2026

0001104659-26-006306424B5

—

423.8 KB

Jan 22, 2026

0001610717-26-000017

Jan 20, 2026

4.9 KB

Jan 22, 2026

0001610717-26-000016

Jan 20, 2026

6.6 KB

8-K

Jan 13, 2026

0001104659-26-0031178-K

Jan 13, 2026

771.6 KB

EFFECT

Dec 8, 2025

9999999995-25-003584

—

2.0 KB

S-3

Nov 13, 2025

0001104659-25-111503S-3

—

1.0 MB

S-8

Nov 13, 2025

0001104659-25-111492FORM S-8

—

205.0 KB

8-K

Nov 13, 2025

0001104659-25-1114848-K

Nov 13, 2025

15.7 MB

10-Q

Nov 6, 2025

0001104659-25-10785210-Q

Sep 30, 2025

10.5 MB

8-K

Nov 6, 2025

0001104659-25-1077808-K

Nov 6, 2025

521.2 KB

SCHEDULE 13G

Nov 4, 2025

0001104659-25-106487

—

21.2 KB

8-K

Sep 8, 2025

0001558370-25-0119118-K

Sep 5, 2025

154.4 KB

10-Q

Aug 7, 2025

0001558370-25-01080310-Q

Jun 30, 2025

10.9 MB

8-K

Aug 7, 2025

0001558370-25-0108028-K

Aug 7, 2025

535.2 KB

25 filings shown

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
3/4/25	DEFA14A	DEFA14A	→
1/30/25	DEFA14A	DEFA14A	→
1/28/25	DEFM14A	DEFM14A	→
1/14/25	PREM14A	PREM14A	→
↓

Coherus Oncology, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(886 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/26/26	4	4	→
1/26/26	4	4	→
1/22/26	4	4	→
1/22/26	4	4	→
6/13/25	4	4	→
6/13/25	4	4	→
↓

Filed	Form	Description
2/5/26	SCHEDULE 13G	SCHEDULE 13G	→
1/30/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/8/25	EFFECT	EFFECT	→
11/4/25	SCHEDULE 13G	SCHEDULE 13G	→
5/15/25	SC TO-I/A	SC TO-I/A	→
4/17/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓